Literature DB >> 12544350

Successful diagnosis of orthotopic rat superficial bladder tumor model by ultrathin cystoscopy.

Hiroshi Asanuma1, Tsunenori Arai, Kenji Seguchi, Satoko Kawauchi, Hiroyuki Satoh, Makoto Kikuchi, Masaru Murai.   

Abstract

PURPOSE: In the orthotopic animal bladder tumor model noninvasive evaluation of the tumor establishment and the therapeutic effect has been difficult. To our knowledge we present the first diagnosis of orthotopic rat superficial bladder tumor model by ultrathin cystoscopy.
MATERIALS AND METHODS: The established AY-27 rat bladder carcinoma cell line was transplanted orthotopically into 22 female Fischer F344 rats. A cell suspension containing 4 x 10 AY-27 cells was instilled into the bladder, which had been conditioned with mild acid washing. To evaluate tumor growth serial cystoscopy was performed via the urethra with an ultrathin endoscope (diameter 0.75 mm.) 5 to 14 days after tumor cell inoculation. At intervals after cystoscopic tumor detection the rats were sacrificed for autopsy and histological examination.
RESULTS: In all 22 rats the orthotopic bladder tumor was established 7 to 10 days after tumor cell implantation and in most it was superficial. Cystoscopy permitted inspection of the urethra and whole bladder surface. We detected all tumors as broad based papillary mass (minimal lesion 1 mm. or less) and inspected its detailed appearance and accurate location.
CONCLUSIONS: The orthotopic rat superficial bladder tumor model and the diagnostic procedure by ultrathin cystoscopy would be ideal system for preclinical evaluation of new potential intravesical therapies.

Entities:  

Mesh:

Year:  2003        PMID: 12544350     DOI: 10.1097/01.ju.0000038092.63280.a0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  pcDNA3.1tdTomato is superior to pDsRed2-N1 for optical fluorescence imaging in the F344/AY-27 rat model of bladder cancer.

Authors:  Vincent Koo; Alvin Lee; Osama Sharaf Eldin; Chris Watson; Peter Hamilton; Kate Williamson
Journal:  Mol Imaging Biol       Date:  2009-12-15       Impact factor: 3.488

2.  Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model.

Authors:  Zhengwen Xiao; Erich Hanel; Allan Mak; Ronald B Moore
Journal:  Clin Med Insights Oncol       Date:  2011-09-21

3.  Experimental rat bladder urothelial cell carcinoma models.

Authors:  Harm C Arentsen; Kees Hendricksen; Egbert Oosterwijk; J Alfred Witjes
Journal:  World J Urol       Date:  2009-02-15       Impact factor: 4.226

4.  Current animal models of bladder cancer: Awareness of translatability (Review).

Authors:  Jie Ding; Ding Xu; Chunwu Pan; Min Ye; Jian Kang; Qiang Bai; Jun Qi
Journal:  Exp Ther Med       Date:  2014-07-11       Impact factor: 2.447

5.  Fluorescence-Based Microendoscopic Sensing System for Minimally Invasive In Vivo Bladder Cancer Diagnosis.

Authors:  Sanghwa Lee; Jeongmin Oh; Minju Cho; Jun Ki Kim
Journal:  Biosensors (Basel)       Date:  2022-08-11

6.  Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models.

Authors:  Kyle G Potts; Chad R Irwin; Nicole A Favis; Desmond B Pink; Krista M Vincent; John D Lewis; Ronald B Moore; Mary M Hitt; David H Evans
Journal:  EMBO Mol Med       Date:  2017-05       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.